44,918 Shares in Phreesia, Inc. $PHR Bought by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership purchased a new stake in shares of Phreesia, Inc. (NYSE:PHR) in the 1st quarter, Holdings Channel reports. The institutional investor purchased 44,918 shares of the company’s stock, valued at approximately $376,000.

A number of other hedge funds have also added to or reduced their stakes in PHR. Tudor Investment Corp ET AL bought a new stake in Phreesia during the third quarter worth about $4,173,000. Cambiar Investors LLC grew its position in Phreesia by 48.9% in the 4th quarter. Cambiar Investors LLC now owns 358,474 shares of the company’s stock worth $6,065,000 after purchasing an additional 117,681 shares during the period. King Luther Capital Management Corp increased its position in Phreesia by 172.6% during the fourth quarter. King Luther Capital Management Corp now owns 268,314 shares of the company’s stock valued at $4,540,000 after acquiring an additional 169,900 shares during the last quarter. Meros Investment Management LP grew its position in Phreesia by 48.5% during the fourth quarter. Meros Investment Management LP now owns 478,274 shares of the company’s stock valued at $8,092,000 after buying an additional 156,137 shares during the period. Finally, SG Americas Securities LLC raised its holdings in Phreesia by 544.3% in the 1st quarter. SG Americas Securities LLC now owns 457,925 shares of the company’s stock worth $3,837,000 after purchasing an additional 386,848 shares during the period. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Price Performance

Shares of NYSE PHR opened at $12.51 on Friday. Phreesia, Inc. has a 52 week low of $7.77 and a 52 week high of $32.76. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.41. The stock has a market capitalization of $773.00 million, a price-to-earnings ratio of 83.37 and a beta of 0.85. The firm has a 50-day simple moving average of $10.28 and a 200-day simple moving average of $10.75.

Phreesia (NYSE:PHR) last issued its earnings results on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.03. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The company had revenue of $130.94 million during the quarter, compared to analysts’ expectations of $130.08 million. During the same period in the prior year, the business earned ($0.07) EPS. The firm’s quarterly revenue was up 12.9% on a year-over-year basis. On average, equities analysts predict that Phreesia, Inc. will post 0.39 earnings per share for the current fiscal year.

Analysts Set New Price Targets

PHR has been the subject of a number of analyst reports. Citigroup reiterated a “market perform” rating on shares of Phreesia in a research note on Friday, May 29th. Weiss Ratings upgraded shares of Phreesia from a “sell (d)” rating to a “sell (d+)” rating in a report on Monday, July 20th. Wall Street Zen upgraded shares of Phreesia from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. KeyCorp decreased their price objective on Phreesia from $15.00 to $12.00 and set an “overweight” rating for the company in a report on Monday, April 13th. Finally, Wells Fargo & Company reaffirmed an “equal weight” rating and set a $9.00 price objective (down from $15.00) on shares of Phreesia in a research report on Wednesday, May 20th. Nine investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $16.65.

Phreesia Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.